Embolization for the treatment of large, complex fibroids in an outpatient setting: A report of 2 cases
- PMID: 36618085
- PMCID: PMC9813576
- DOI: 10.1016/j.radcr.2022.11.036
Embolization for the treatment of large, complex fibroids in an outpatient setting: A report of 2 cases
Abstract
Uterine leiomyomas are the most common benign pelvic tumors in premenopausal women, causing significant morbidity. Uterine fibroid embolization is a minimally invasive alternative to traditional open or laparoscopic surgeries for the management of symptomatic uterine leiomyoma. For large fibroids, hospitalization after treatment is often required. However, there are limited data on patients with large, complex uterine leiomyomas treated by embolization. This report of 2 cases describes 2 females with large, complex fibroids causing pain and decreased quality of life who were evaluated and treated with embolization in the outpatient setting. Each patient underwent transradial cannulation and uterine artery embolization under local anesthesia or conscious sedation and returned home without complication. For women wishing to preserve their uterus, uterine fibroid embolization is an effective nonsurgical alternative to hysterectomy and myomectomy in an outpatient setting. If standard protocols are followed, embolization by way of transradial artery catheterization is safe for the treatment of large, complex, symptomatic fibroids in the outpatient setting; however, additional studies with larger cohorts are warranted. Accessing the uterine arteries transradially reduces the risk of intra- and post-operative complications for patients, reduces their time spent in a hospital, and minimizes operating costs.
Keywords: Endovascular embolization; Fibroid embolization; Minimally invasive; Uterine fibroid embolization; Uterine fibroids; Uterine leiomyoma.
© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Figures




Similar articles
-
The management of uterine leiomyomas.J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8. J Obstet Gynaecol Can. 2015. PMID: 25767949
-
The management of uterine leiomyomas.J Obstet Gynaecol Can. 2003 May;25(5):396-418; quiz 419-22. J Obstet Gynaecol Can. 2003. PMID: 12738981
-
[The percutaneous treatment of uterine fibromas by means of transcatheter arterial embolization].Radiol Med. 2000 Jul-Aug;100(1-2):48-55. Radiol Med. 2000. PMID: 11109452 Italian.
-
Therapeutic management of uterine fibroid tumors: updated French guidelines.Eur J Obstet Gynecol Reprod Biol. 2012 Dec;165(2):156-64. doi: 10.1016/j.ejogrb.2012.07.030. Epub 2012 Aug 29. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22939241 Review.
-
SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004.Int J Gynaecol Obstet. 2005 Jun;89(3):305-18. doi: 10.1016/j.ijgo.2005.03.013. Int J Gynaecol Obstet. 2005. PMID: 16001461 Review.
Cited by
-
Tanshinone-I for the treatment of uterine fibroids: Molecular docking, simulation, and density functional theory investigations.Saudi Pharm J. 2023 Jun;31(6):1061-1076. doi: 10.1016/j.jsps.2023.05.002. Epub 2023 May 8. Saudi Pharm J. 2023. PMID: 37250358 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources